GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OSTO:VIVE) » Definitions » Operating Cash Flow per Share

Vivesto AB (OSTO:VIVE) Operating Cash Flow per Share : kr-0.06 (TTM As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Vivesto AB Operating Cash Flow per Share?

Vivesto AB's operating cash flow per share for the three months ended in Mar. 2025 was kr-0.01. Vivesto AB's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.06.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 35.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Vivesto AB's Operating Cash Flow per Share or its related term are showing as below:

OSTO:VIVE' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -149.9   Med: 9.4   Max: 72
Current: 35.3

During the past 13 years, Vivesto AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.00% per year. The lowest was -149.90% per year. And the median was 9.40% per year.

OSTO:VIVE's 3-Year OCF Growth Rate is ranked better than
77.82% of 780 companies
in the Drug Manufacturers industry
Industry Median: 8.85 vs OSTO:VIVE: 35.30

Vivesto AB Operating Cash Flow per Share Historical Data

The historical data trend for Vivesto AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Operating Cash Flow per Share Chart

Vivesto AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.33 -0.17 -0.13 -0.09

Vivesto AB Quarterly Data
Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.02 -0.02 -0.02 -0.01

Competitive Comparison of Vivesto AB's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivesto AB's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vivesto AB's Price-to-Operating-Cash-Flow falls into.


;
;

Vivesto AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Vivesto AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=-47.246/538.043
=-0.09

Vivesto AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=-3.085/538.043
=-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivesto AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivesto AB Business Description

Industry
Traded in Other Exchanges
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.